340 related articles for article (PubMed ID: 19944029)
21. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of peripheral nerve sheath tumors of the second cervical nerve root in 60 surgically treated patients.
Goel A; Muzumdar D; Nadkarni T; Desai K; Dange N; Chagla A
J Neurosurg Spine; 2008 Feb; 8(2):129-34. PubMed ID: 18248284
[TBL] [Abstract][Full Text] [Related]
23. Low-grade malignant triton tumor in the lumbar spine: a rare variant of malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation.
Prieto R; Pascual JM; García-Cabezas MA; López-Barea F; Barrios L; González-Llanos F
Neuropathology; 2012 Apr; 32(2):180-9. PubMed ID: 21732991
[TBL] [Abstract][Full Text] [Related]
24. Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases.
Hirose T; Scheithauer BW; Sano T
Am J Surg Pathol; 1998 Nov; 22(11):1368-78. PubMed ID: 9808129
[TBL] [Abstract][Full Text] [Related]
25. Surgical strategies for managing foraminal nerve sheath tumors: the emerging role of CyberKnife ablation.
Murovic JA; Charles Cho S; Park J
Eur Spine J; 2010 Feb; 19(2):242-56. PubMed ID: 19798517
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
Miettinen MM; Antonescu CR; Fletcher CDM; Kim A; Lazar AJ; Quezado MM; Reilly KM; Stemmer-Rachamimov A; Stewart DR; Viskochil D; Widemann B; Perry A
Hum Pathol; 2017 Sep; 67():1-10. PubMed ID: 28551330
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.
Miao R; Wang H; Jacobson A; Lietz AP; Choy E; Raskin KA; Schwab JH; Deshpande V; Nielsen GP; DeLaney TF; Cote GM; Hornicek FJ; Chen YE
Radiother Oncol; 2019 Aug; 137():61-70. PubMed ID: 31078939
[TBL] [Abstract][Full Text] [Related]
28. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
29. Retroperitoneal malignant peripheral nerve sheath tumor associated with scoliosis in neurofibromatosis.
Ogose A; Hotta T; Uchiyama S; Matsumoto Y; Hasegawa K; Takahashi HE
J Spinal Disord; 2001 Jun; 14(3):260-3. PubMed ID: 11389379
[TBL] [Abstract][Full Text] [Related]
30. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
31. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
33. Malignant peripheral nerve sheath tumour of the cervical vagus nerve in a neurofibromatosis type 1 patient.
Molina AR; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1458-62. PubMed ID: 17113542
[TBL] [Abstract][Full Text] [Related]
34. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
[TBL] [Abstract][Full Text] [Related]
35. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
36. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
Malerba M; Garofalo A
Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
[TBL] [Abstract][Full Text] [Related]
37. Foraminal nerve sheath tumors: intermediate follow-up after cyberknife radiosurgery.
Murovic JA; Gibbs IC; Chang SD; Mobley BC; Park J; Adler JR
Neurosurgery; 2009 Feb; 64(2 Suppl):A33-43. PubMed ID: 19165072
[TBL] [Abstract][Full Text] [Related]
38. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
Friedrich RE; Kluwe L; Fünsterer C; Mautner VF
Anticancer Res; 2005; 25(3A):1699-702. PubMed ID: 16033085
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
40. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
